Featured Posts
JAMA Study on Price of Diabetes Medicines is Deceiving and Threatens Medical Innovation
In a recent study by the activist-funded JAMA Network, researchers erroneously “determined” that the price of diabetes medicines, like insulins, SGLT2 inhibitors, and…
Commentary
Biden Budget Would Expand Devastating Drug Price Controls
President Biden’s new proposed budget for Fiscal Year 2025 calls for an expansion of the drug price controls passed in the Inflation Reduction Act (IRA). These…
Commentary
ATR Supports Bipartisan Bill that Expands Health Savings Accounts
In February, the House of Representatives placed H.R.5688, the Bipartisan HSA Improvement Act, on the Union Calendar making it eligible for floor consideration. This recent movement…
Commentary
Filtered Posts
Norquist Warns of Dem Drug Price Controls, New IRS Reporting Regime
Commentary
Norquist Warns of Dem Drug Price Controls, New IRS Reporting Regime
Commentary
Study: Democrats’ $3.5 Trillion Bill Will Lead to Up To 324 Fewer New Medicines
Commentary